Woven Science

Woven Science is a private investment firm dedicated to advancing mental health and wellness through innovative approaches, including psychedelic therapies. The firm invests in early-stage companies that are developing and commercializing treatments aimed at improving mental well-being. By supporting these ventures, Woven Science seeks to address the growing global mental health crisis with novel solutions.

The firm's investment strategy centers on identifying and nurturing companies that integrate psychedelic models of care into their offerings. This includes backing drug development initiatives, health technology innovations, and wellness products that leverage the therapeutic potential of psychedelics. Woven Science also emphasizes ethical practices by facilitating access and benefit-sharing between psychedelic companies and indigenous communities, ensuring that the origins of these therapies are respected and preserved.

Since its inception, Woven Science has been actively involved in the psychedelic sector, participating in significant funding rounds and partnerships. Notably, in May 2021, the firm launched a psychedelic care platform with an oversubscribed $8.5 million seed financing. This initiative aims to provide holistic mental health solutions by combining psychedelic therapies with comprehensive wellness practices. The firm's commitment to innovation and ethical responsibility positions it as a key player in the evolving landscape of mental health care.

Woven Science's approach reflects a growing recognition of the potential of psychedelic substances in treating mental health disorders. By investing in this emerging field, the firm contributes to the development of alternative therapies that could offer new hope to individuals seeking effective mental health treatments. Through strategic investments and partnerships, Woven Science continues to support the integration of psychedelic therapies into mainstream mental health care, advocating for a more inclusive and diverse approach to wellness.